Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
US5102663A · kind A · utility
24Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 1988 |
| Grant date | Apr 7, 1992 |
| Priority date | — |
| Expiry date | Oct 18, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/842
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a vaccine for stimulating or enhancing in a subject to whom the vaccine is administered, production of antibodies directed against 9-O-acetyl GD3 ganglioside comprising an amount of purified 9-O-acetyl GD3 ganglioside effective to stimulate or enhance antibody production This invention was made with government support under Grant Numbers CA-40532 and CA-43971, National Cancer Institute, Department of Health and Human Services. Accordingly, the U.S. Government has certain rights in the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.